The importance of non-transferrin bound iron in disorders of iron metabolism - PubMed
Review
The importance of non-transferrin bound iron in disorders of iron metabolism
W Breuer et al. Transfus Sci. 2000 Dec.
Abstract
The concept of non-transferrin bound iron (NTBI) was introduced 22 years ago by Hershko et al. (Brit. J. Haematol. 40 (1978) 255). It stemmed from a suspicion that, in iron overloaded patients, the large amounts of excess iron released into the circulation are likely to exceed the serum transferrin (Tf) iron-binding capacity (TIBC), leading to the appearance of various forms of iron not bound to Tf. In accordance with this assumption, NTBI was initially looked for and detected in patients with > or = 100% Tf-saturation. As techniques for its detection became more sophisticated and sensitive, NTBI was also found in conditions where Tf was not fully saturated, leading to a revision of the original view of NTBI as a simple spillover phenomenon. In this review, we will discuss some of the properties of NTBI, methods for its detection, its significance and potential value as an indicator for therapeutic regimens of iron chelation and supplementation.
Similar articles
-
Breuer W, Ghoti H, Shattat A, Goldfarb A, Koren A, Levin C, Rachmilewitz E, Cabantchik ZI. Breuer W, et al. Am J Hematol. 2012 Jan;87(1):55-61. doi: 10.1002/ajh.22203. Epub 2011 Nov 28. Am J Hematol. 2012. PMID: 22125177
-
Brissot P, Bolder U, Schteingart CD, Arnaud J, Hofmann AF. Brissot P, et al. Hepatology. 1997 Jun;25(6):1457-61. doi: 10.1002/hep.510250625. Hepatology. 1997. PMID: 9185768
-
Matinaho S, Parkkinen J. Matinaho S, et al. Transfusion. 2005 Jun;45(6):927-33. doi: 10.1111/j.1537-2995.2005.04410.x. Transfusion. 2005. PMID: 15934991
-
Non-transferrin bound iron: a key role in iron overload and iron toxicity.
Brissot P, Ropert M, Le Lan C, Loréal O. Brissot P, et al. Biochim Biophys Acta. 2012 Mar;1820(3):403-10. doi: 10.1016/j.bbagen.2011.07.014. Epub 2011 Aug 9. Biochim Biophys Acta. 2012. PMID: 21855608 Review.
-
[Non-transferrin-bound iron: a promising biomarker in iron overload disorders].
Maas RP, Voets PJ, de Swart L, Swinkels DW. Maas RP, et al. Ned Tijdschr Geneeskd. 2013;157(49):A6258. Ned Tijdschr Geneeskd. 2013. PMID: 24299624 Review. Dutch.
Cited by
-
Kwiatkowski JL. Kwiatkowski JL. J Blood Med. 2011;2:135-49. doi: 10.2147/JBM.S13065. Epub 2011 Sep 21. J Blood Med. 2011. PMID: 22287873 Free PMC article.
-
In vivo behavior of NTBI revealed by automated quantification system.
Ito S, Ikuta K, Kato D, Lynda A, Shibusa K, Niizeki N, Toki Y, Hatayama M, Yamamoto M, Shindo M, Iizuka N, Kohgo Y, Fujiya M. Ito S, et al. Int J Hematol. 2016 Aug;104(2):175-81. doi: 10.1007/s12185-016-2002-6. Epub 2016 Apr 16. Int J Hematol. 2016. PMID: 27086349
-
Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes.
Mollet IG, Patel D, Govani FS, Giess A, Paschalaki K, Periyasamy M, Lidington EC, Mason JC, Jones MD, Game L, Ali S, Shovlin CL. Mollet IG, et al. PLoS One. 2016 Feb 11;11(2):e0147990. doi: 10.1371/journal.pone.0147990. eCollection 2016. PLoS One. 2016. PMID: 26866805 Free PMC article.
-
Yanpanitch OU, Hatairaktham S, Charoensakdi R, Panichkul N, Fucharoen S, Srichairatanakool S, Siritanaratkul N, Kalpravidh RW. Yanpanitch OU, et al. Oxid Med Cell Longev. 2015;2015:537954. doi: 10.1155/2015/537954. Epub 2015 May 19. Oxid Med Cell Longev. 2015. PMID: 26078808 Free PMC article. Clinical Trial.
-
Disruption of Iron Regulation after Radiation and Donor Cell Infusion.
Karoopongse E, Marcondes AM, Yeung C, Holman Z, Kowdley KV, Campbell JS, Deeg HJ. Karoopongse E, et al. Biol Blood Marrow Transplant. 2016 Jul;22(7):1173-1181. doi: 10.1016/j.bbmt.2016.03.031. Epub 2016 Apr 7. Biol Blood Marrow Transplant. 2016. PMID: 27060441 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous